These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37315161)

  • 1. Progression from different blood glucose states to cardiovascular diseases: a prospective study based on multi-state model.
    Chen Y; Xu L; Cheng Z; Zhang D; Yang J; Yin C; Li S; Li J; Hu Y; Wang Y; Liu Y; Wang Z; Zhang L; Chen R; Dou Q; Bai Y
    Eur J Prev Cardiol; 2023 Oct; 30(14):1482-1491. PubMed ID: 37315161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study.
    Vistisen D; Kivimäki M; Perreault L; Hulman A; Witte DR; Brunner EJ; Tabák A; Jørgensen ME; Færch K
    Diabetologia; 2019 Aug; 62(8):1385-1390. PubMed ID: 31123789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study.
    Moazzeni SS; Hizomi Arani R; Deravi N; Hasheminia M; Khalili D; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2021 Jul; 20(1):141. PubMed ID: 34253199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
    Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Yoshida Y; Chen Z; Baudier RL; Krousel-Wood M; Anderson AH; Fonseca VA; Mauvais-Jarvis F
    Atherosclerosis; 2022 Mar; 344():13-19. PubMed ID: 35114556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion From Pre-Diabetes Mellitus to Normoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in a Chinese Population: A Prospective Cohort Study.
    Liu X; Wu S; Song Q; Wang X
    J Am Heart Assoc; 2021 Feb; 10(3):e019045. PubMed ID: 33496188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study.
    Kramer CK; von Mühlen D; Jassal SK; Barrett-Connor E
    J Intern Med; 2010 Jun; 267(6):561-6. PubMed ID: 20337857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
    JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of prediabetes in older adults from a population-based longitudinal study.
    Shang Y; Marseglia A; Fratiglioni L; Welmer AK; Wang R; Wang HX; Xu W
    J Intern Med; 2019 Sep; 286(3):326-340. PubMed ID: 31165572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.
    Einarson TR; Acs A; Ludwig C; Panton UH
    Cardiovasc Diabetol; 2018 Jun; 17(1):83. PubMed ID: 29884191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of combined healthy lifestyle with risk of adverse outcomes in patients with prediabetes.
    Xu X; Li J; Yu Y; Tan X; Xu F; Wang B; Wang N; Lu Y
    Diabetes Metab Res Rev; 2024 May; 40(4):e3795. PubMed ID: 38546142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.
    Kaze AD; Santhanam P; Musani SK; Ahima R; Echouffo-Tcheugui JB
    J Am Heart Assoc; 2021 Apr; 10(7):e016947. PubMed ID: 33728932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease.
    Salinero-Fort MA; Mostaza J; Lahoz C; Cárdenas-Valladolid J; Vicente-Díez JI; Gómez-Campelo P; de Miguel-Yanes JM
    BMC Geriatr; 2022 Mar; 22(1):224. PubMed ID: 35303825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States.
    Daviglus ML; Talavera GA; Avilés-Santa ML; Allison M; Cai J; Criqui MH; Gellman M; Giachello AL; Gouskova N; Kaplan RC; LaVange L; Penedo F; Perreira K; Pirzada A; Schneiderman N; Wassertheil-Smoller S; Sorlie PD; Stamler J
    JAMA; 2012 Nov; 308(17):1775-84. PubMed ID: 23117778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.
    Thomas G; Khunti K; Curcin V; Molokhia M; Millett C; Majeed A; Paul S
    Diabetes Obes Metab; 2014 Apr; 16(4):317-25. PubMed ID: 24118783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study.
    Wong CKH; Lau KTK; Tang EHM; Lee CH; Lee CYY; Woo YC; Au ICH; Tan KCB; Lui DTW
    Cardiovasc Diabetol; 2022 Jun; 21(1):92. PubMed ID: 35658864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.